Duchnowska, R., Biernat, W., Szostakiewicz, B., Sperinde, J., Piette, F., Haddad, M., . . . Jassem, J. (2012). Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2(+) Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy. AlphaMed Press.
Παραπομπή Chicago StyleDuchnowska, Renata, et al. Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2(+) Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy. AlphaMed Press, 2012.
Παραπομπή MLADuchnowska, Renata, et al. Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2(+) Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy. AlphaMed Press, 2012.